Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
First Claim
Patent Images
1. A method of treating a leukemia selected from chronic neutrophilic leukemia and atypical chronic myeloid leukemia in a patient in need thereof, comprising administering to said patient a therapeutically effective amount of a selective JAK1 inhibitor.
2 Assignments
0 Petitions
Accused Products
Abstract
This invention relates to JAK selective inhibitors for use in treatment of chronic neutrophilic leukemia and atypical chronic myeloid leukemia in patients.
-
Citations
20 Claims
- 1. A method of treating a leukemia selected from chronic neutrophilic leukemia and atypical chronic myeloid leukemia in a patient in need thereof, comprising administering to said patient a therapeutically effective amount of a selective JAK1 inhibitor.
Specification